+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Contract Development & Manufacturing Market Research Report by Service, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 134 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124559
UP TO OFF until Dec 31st 2022
The United States Pharmaceutical Contract Development & Manufacturing Market size was estimated at USD 18.58 billion in 2021, USD 20.09 billion in 2022, and is projected to grow at a CAGR 8.52% to reach USD 30.36 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Contract Development & Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Service, the market was studied across Biologics Manufacturing Services, Drug Development Services, Pharmaceutical Manufacturing Services, and Secondary Packaging Services. The Biologics Manufacturing Services is further studied across Biologics API Manufacturing Services and Biologics FDF Manufacturing Services. The Pharmaceutical Manufacturing Services is further studied across Pharmaceutical API Manufacturing and Pharmaceutical FDF Manufacturing. The Pharmaceutical API Manufacturing is further studied across Capsule Manufacturing Services, Oral Liquid Manufacturing Services, Parenteral/Injectable Manufacturing Services, and Tablet Manufacturing Services.
  • Based on End User, the market was studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-Size Pharma.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Contract Development & Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Development & Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Pharmaceutical Contract Development & Manufacturing Market, including AbbVie, Inc., Aenova Group GmbH, Almac Group, AMRI Global, C.H. Boehringer Sohn AG & Ko. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation, Delwis Healthcare Pvt Ltd., Evonik Industries AG, Famar Health Care Services, Fareva, Jubilant Life Sciences Limited, Lonza Group AG, Pfizer Inc., Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Thermo Fisher Scientific Inc., and Vetter Pharma-Fertigung GmbH & Co. KG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Pharmaceutical Contract Development & Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Pharmaceutical Contract Development & Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Pharmaceutical Contract Development & Manufacturing Market?
4. What is the competitive strategic window for opportunities in the United States Pharmaceutical Contract Development & Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the United States Pharmaceutical Contract Development & Manufacturing Market?
6. What is the market share of the leading vendors in the United States Pharmaceutical Contract Development & Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the United States Pharmaceutical Contract Development & Manufacturing Market?
Frequently Asked Questions about the U.S. Pharmaceutical Contract Development & Manufacturing Market

What is the estimated value of the U.S. Pharmaceutical Contract Development & Manufacturing Market?

The U.S. Pharmaceutical Contract Development & Manufacturing Market was estimated to be valued at $18.58 Billion in 2021.

What is the growth rate of the U.S. Pharmaceutical Contract Development & Manufacturing Market?

The growth rate of the U.S. Pharmaceutical Contract Development & Manufacturing Market is 8.5%, with an estimated value of $30.36 Billion by 2027.

What is the forecasted size of the U.S. Pharmaceutical Contract Development & Manufacturing Market?

The U.S. Pharmaceutical Contract Development & Manufacturing Market is estimated to be worth $30.36 Billion by 2027.

Who are the key companies in the U.S. Pharmaceutical Contract Development & Manufacturing Market?

Key companies in the U.S. Pharmaceutical Contract Development & Manufacturing Market include AbbVie, Inc., Aenova Group GmbH, Almac Group, AMRI Global, C.H. Boehringer Sohn AG & Ko. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation and Evonik Industries AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Contract Development & Manufacturing Market, by Service
6.1. Introduction
6.2. Biologics Manufacturing Services
6.2.1. Biologics Api Manufacturing Services
6.2.2. Biologics Fdf Manufacturing Services
6.3. Drug Development Services
6.4. Pharmaceutical Manufacturing Services
6.4.1. Pharmaceutical Api Manufacturing
6.4.1.1. Capsule Manufacturing Services
6.4.1.2. Oral Liquid Manufacturing Services
6.4.1.3. Parenteral/Injectable Manufacturing Services
6.4.1.4. Tablet Manufacturing Services
6.4.2. Pharmaceutical Fdf Manufacturing
6.5. Secondary Packaging Services
7. Pharmaceutical Contract Development & Manufacturing Market, by End-user
7.1. Introduction
7.2. Big Pharma
7.3. Generic Pharmaceutical Companies
7.4. Small & Mid-Size Pharma
8. California Pharmaceutical Contract Development & Manufacturing Market9. Florida Pharmaceutical Contract Development & Manufacturing Market10. Illinois Pharmaceutical Contract Development & Manufacturing Market11. New York Pharmaceutical Contract Development & Manufacturing Market12. Ohio Pharmaceutical Contract Development & Manufacturing Market13. Pennsylvania Pharmaceutical Contract Development & Manufacturing Market14. Texas Pharmaceutical Contract Development & Manufacturing Market
15. Competitive Landscape
15.1. Fpnv Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, by Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Abbvie, Inc.
16.2. Aenova Group GmbH
16.3. Almac Group
16.4. Amri Global
16.5. C.H. Boehringer Sohn AG & Ko. Kg
16.6. Cambrex Corporation
16.7. Catalent, Inc.
16.8. Danaher Corporation
16.9. Delwis Healthcare Pvt Ltd.
16.10. Evonik Industries Ag
16.11. Famar Health Care Services
16.12. Fareva
16.13. Jubilant Life Sciences Limited
16.14. Lonza Group Ag
16.15. Pfizer Inc.
16.16. Recipharm Ab
16.17. Serum Institute of India Ltd.
16.18. Siegfried Holding Ag
16.19. Thermo Fisher Scientific Inc.
16.20. Vetter Pharma-Fertigung GmbH & Co. Kg
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET DYNAMICS
FIGURE 8. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2027
FIGURE 11. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 12. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 14. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 16. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, 2019-2027 (USD BILLION)
FIGURE 18. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 19. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 20. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 21. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2019-2027 (USD BILLION)
FIGURE 22. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 23. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 24. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 25. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 26. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 27. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 28. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 29. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, 2019-2027 (USD BILLION)
FIGURE 30. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 31. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, 2019-2027 (USD BILLION)
FIGURE 32. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 33. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, 2019-2027 (USD BILLION)
FIGURE 34. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 35. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 36. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2027
FIGURE 38. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIG PHARMA, 2019-2027 (USD BILLION)
FIGURE 39. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 40. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2019-2027 (USD BILLION)
FIGURE 41. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 42. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2019-2027 (USD BILLION)
FIGURE 43. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 44. CALIFORNIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. FLORIDA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. ILLINOIS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. NEW YORK PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. OHIO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. PENNSYLVANIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. TEXAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 52. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 53. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 5. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 10. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CAPSULE MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ORAL LIQUID MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 15. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY TABLET MANUFACTURING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 16. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY STATE, 2019-2027 (USD BILLION)
TABLE 17. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SECONDARY PACKAGING SERVICES, BY STATE, 2019-2027 (USD BILLION)
TABLE 18. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 19. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 20. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 21. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 22. CALIFORNIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 23. CALIFORNIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 24. CALIFORNIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 25. FLORIDA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 26. FLORIDA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 27. FLORIDA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 28. ILLINOIS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 29. ILLINOIS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 30. ILLINOIS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 31. NEW YORK PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 32. NEW YORK PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 33. NEW YORK PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 34. OHIO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 35. OHIO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 36. OHIO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 37. PENNSYLVANIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 38. PENNSYLVANIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 39. PENNSYLVANIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 40. TEXAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 41. TEXAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE, 2019-2027 (USD BILLION)
TABLE 42. TEXAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
TABLE 43. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 44. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 45. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 46. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET RANKING
TABLE 47. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 48. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET MERGER & ACQUISITION
TABLE 49. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 50. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 51. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET INVESTMENT & FUNDING
TABLE 52. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 53. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie, Inc.
  • Aenova Group GmbH
  • Almac Group
  • AMRI Global
  • C.H. Boehringer Sohn AG & Ko. KG
  • Cambrex Corporation
  • Catalent, Inc.
  • Danaher Corporation
  • Delwis Healthcare Pvt Ltd.
  • Evonik Industries AG
  • Famar Health Care Services
  • Fareva
  • Jubilant Life Sciences Limited
  • Lonza Group AG
  • Pfizer Inc.
  • Recipharm AB
  • Serum Institute of India Ltd.
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Vetter Pharma-Fertigung GmbH & Co. KG

Methodology

Loading
LOADING...